Page 6 - Summit Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

February 10, 2021 The link between big data and intelligent actions SHENZHEN, China, Feb. 10, 2021 /PRNewswire/ -- Rather than focusing on artificial part of AI technology, we should also make the technology "accessible, affordable and actionable", in order to create real business value and benefit all humankind, said Dr. Wanli Min, Founder and CEO of North Summit Capital, on February 9th, during a keynote at the Global M&A Conversation 2021 held by Mergermarket. Joined by acquirers, investors, advisors and lenders around the world, the Mergermarket forum aims to help industry players to gain...

China Digest: Sequoia backs Neurophth; TransThera bags over $50m February 9, 2021 Wuhan Neurophth Biological Technology has secured 400 million yuan ($62 million) in a Series B round of financing jointly led by Guofang FOF and InnoVision Capital, while Nanjing TransThera Biosciences has garnered over $50 million led by Co-Stone Asset Management. Sequoia backs gene therapy company Neurophth Chinese ophthalmic gene therapy technology company Wuhan Neurophth Biological Technology Co., Ltd has secured 400 million yuan ($62 million) in a Series B round of financing, according to a company statemen...

Alpha Vee Solutions Launches Research Partnership with Summit Capital Solutions News provided by Share this article Share this article BOSTON, Jan. 12, 2021 /PRNewswire/ -- Alpha Vee Solutions and Summit Capital Solutions has reached agreement to use the Alpha Vee Solutions research technology platform supporting Summit's fast growth.  Summit provides investment professionals direct access to leading tradeable investment strategies from asset managers and index providers.  This new investable research technology partnership will yield two exciting products exclusively released on the Virt...